C. Nichols
Corporate Officer/Principal presso ALKERMES PLC
Patrimonio netto: 2 M $ in data 30/04/2024
Profilo
C.
Todd Nichols is currently the Chief Commercial Officer & Senior Vice President at Alkermes Plc.
Prior to his current position, he served as the Senior Vice President-Sales & Marketing at Alkermes, Inc. from 2019 to 2020.
Before that, he was the Vice President-Marketing & Sales at Celgene Corp.
from 2018 to 2019.
He also held a position as Vice President-US Sales & Field Operation at Biogen, Inc. Mr. Nichols completed his undergraduate degree at Elon University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
18/03/2024 | 65 911 ( 0.04% ) | 2 M $ | 30/04/2024 |
Posizioni attive di C. Nichols
Società | Posizione | Inizio |
---|---|---|
ALKERMES PLC | Corporate Officer/Principal | - |
Precedenti posizioni note di C. Nichols
Società | Posizione | Fine |
---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Vendite & Marketing | 01/05/2020 |
CELGENE | Vendite & Marketing | 01/01/2019 |
BIOGEN INC. | Vendite & Marketing | 01/01/2017 |
Formazione di C. Nichols
Elon University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ALKERMES PLC | Health Technology |
BIOGEN INC. | Health Technology |
Aziende private | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- C. Nichols